bioLytical Laboratories clinical trials
The registry lists 16 studies whose lead sponsor is bioLytical Laboratories. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 4, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 16studies on the registry
- 6open to participants now
- 6reach primary completion within a year
Get an email when these change. Save the bioLytical Laboratories studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Coming up
6 of bioLytical Laboratories’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- 1NNov ’26’26
- 2DDec
- 1JJan ’27’27
- FFeb
- 2MMar
- AApr
- MMay
- JJun
- JJul
- AAug
- SSep
- OOct
- NNov
All 6
- Nov 2026Performance Study of the INSTI® and TruPlex Rapid Blood Typing PlatformsNCT07770360
- Dec 2026A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid TestNCT07563309
- Dec 2026A Study to Evaluate the Performance, Usability, and Contrived Result Interpretation of iStatis Gonorrhea Antigen TestNCT07569900
- Jan 2027A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid TestNCT07569913
- Mar 2027Study to Evaluate the Performance of the INSTI® HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV InfectionNCT07904403
Show 1 moreShow fewer
Add all 6 to your calendar (.ics) → With an account.
What changed recently
From the registry's own updates since Oct 14, 2026.
Started recruiting1
Newly registered2
- Study to Evaluate the Performance of the INSTI® HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV InfectionOct 29, 2026NCT07904403
- Clinical Study to Evaluate the Performance of the INSTI® HCV Antibody Test for CLIA-Waived UseOct 29, 2026NCT07904416
All 16 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 07
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 424
- 25
- 426
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to bioLytical Laboratories.
- bioLytical Laboratories16 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 16 of 16.
- A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid TestRecruitingNCT07569913Not applicable
- Study to Evaluate the Performance of the INSTI® HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV InfectionNot yet recruitingNCT07904403Not applicable
- Clinical Study to Evaluate the Performance of the INSTI® HCV Antibody Test for CLIA-Waived UseNot yet recruitingNCT07904416Not applicable
- A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid TestRecruitingNCT07563309Not applicable
- A Study to Evaluate the Performance, Usability, and Contrived Result Interpretation of iStatis Gonorrhea Antigen TestRecruitingNCT07569900Not applicable
- Performance Study of the INSTI® and TruPlex Rapid Blood Typing PlatformsNot yet recruitingNCT07770360Not applicable
- A Study to Evaluate the Performance of INSTI® HIV Self Test When Performed by Unobserved Intended Users in the USCompletedNCT07061912Not applicable
- A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-TestCompletedNCT06368453Not applicable
- A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care SitesCompletedNCT06368466Not applicable
- Trial of Hepatitis C Self-Testing in the Hands of Untrained Lay UsersCompletedNCT06369116Not applicable
- Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site SettingsCompletedNCT06368479Not applicable
- Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis Syphilis Ab Test at the Point- Of-Care SitesCompletedNCT06365606Not applicable
- Retrospective Study of iStatis Syphilis Ab Test (POC)CompletedNCT06367621
- INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result InterpretationCompletedNCT06357819
- Evaluation of Clinical Performance and Usability of iStatis COVID-19 Ag Rapid Test at POCCompletedNCT05514691Not applicable
- Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV InfectionCompletedNCT00514605Phase 2/3